Assessment of the impact of nonavalent human papillomavirus vaccine on disease clearance time in women with active infection.

Rev Bras Ginecol Obstet · 2026 · PMC13399362 · PMID 42500176

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

did not reach statistical significancep=0.069so close (0.05 < p ≤ 0.1)

A higher disease persistence rate was also found among HPV16/18-positive women, however this last result did not reach statistical significance (p=0.069) ( Table 5 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.